Clinical Trial Update: A Phase 1 Study of ProMetic Plasminogen (Human) Intravenous in Adults and Children With Plasminogen Deficiency [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating intravenous human plasminogen in adults and children with plasminogen deficiency. The trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoplasminogenemia
• Type Plasminogen Deficiency

Drugs mentioned

• ProMetic Plasminogen (Human) Intravenous (plasminogen)

Snippet

Sponsor: Prometic Biotherapeutics, Inc. | Conditions: Type I Plasminogen Deficiency, Hypoplasminogenemia | Phase 1 | Status: COMPLETED